Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Investigation of the psychometric properties of the inclusion body myositis functional rating scale with rasch analysis.

Ramdharry G, Morrow J, Hudgens S, Skorupinska I, Gwathmey K, Currence M, Herbelin L, Jawdat O, Pasnoor M, Mcvey A, Barohn RJ, Burns TM, Dimachkie MM, Amato AA, Hanna MG, Machado PM.

Muscle Nerve. 2019 Aug;60(2):161-168. doi: 10.1002/mus.26521. Epub 2019 Jun 7. Erratum in: Muscle Nerve. 2019 Oct;60(4):484.

PMID:
31107564
2.

Satisfactory Response With Achieving Maintenance Low-Dose Prednisone in Generalized Myasthenia Gravis.

Abuzinadah AR, Jabari D, Jawdat O, Pasnoor M, Glenn M, Herbelin L, McVey AL, Barohn RJ, Dimachkie MM.

J Clin Neuromuscul Dis. 2018 Dec;20(2):49-59. doi: 10.1097/CND.0000000000000219.

3.

Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial.

Statland JM, Moore D, Wang Y, Walsh M, Mozaffar T, Elman L, Nations SP, Mitsumoto H, Fernandes JA, Saperstein D, Hayat G, Herbelin L, Karam C, Katz J, Wilkins HM, Agbas A, Swerdlow RH, Santella RM, Dimachkie MM, Barohn RJ; Rasagiline Investigators of the Muscle Study Group and Western ALS Consortium.

Muscle Nerve. 2019 Feb;59(2):201-207. doi: 10.1002/mus.26335. Epub 2018 Nov 26.

PMID:
30192007
4.

Measuring Clinical Treatment Response in Myasthenia Gravis.

Barnett C, Herbelin L, Dimachkie MM, Barohn RJ.

Neurol Clin. 2018 May;36(2):339-353. doi: 10.1016/j.ncl.2018.01.006. Review.

5.

An instrumented timed up and go in facioscapulohumeral muscular dystrophy.

Huisinga J, Bruetsch A, Mccalley A, Currence M, Herbelin L, Jawdat O, Pasnoor M, Dimachkie M, Barohn R, Statland J.

Muscle Nerve. 2018 Mar;57(3):503-506. doi: 10.1002/mus.25955. Epub 2017 Oct 6.

6.

Less is More in Diabetic Neuropathy Diagnosis: Comparison of Quantitative Sudomotor Axon Reflex and Skin Biopsy.

Abuzinadah AR, Kluding P, Wright D, DʼSilva L, Ryals J, Hendry B, Jawdat O, Herbelin L, McVey AL, Barohn RJ, Dimachkie MM, Pasnoor M.

J Clin Neuromuscul Dis. 2017 Sep;19(1):5-11. doi: 10.1097/CND.0000000000000150.

PMID:
28827483
7.

A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization.

Brown AR, Gajewski BJ, Aaronson LS, Mudaranthakam DP, Hunt SL, Berry SM, Quintana M, Pasnoor M, Dimachkie MM, Jawdat O, Herbelin L, Barohn RJ.

Trials. 2016 Aug 31;17(1):428. doi: 10.1186/s13063-016-1544-5.

8.

A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.

Pasnoor M, He J, Herbelin L, Burns TM, Nations S, Bril V, Wang AK, Elsheikh BH, Kissel JT, Saperstein D, Shaibani JA, Jackson C, Swenson A, Howard JF Jr, Goyal N, David W, Wicklund M, Pulley M, Becker M, Mozaffar T, Benatar M, Pazcuzzi R, Simpson E, Rosenfeld J, Dimachkie MM, Statland JM, Barohn RJ; Methotrexate in MG Investigators of the Muscle Study Group.

Neurology. 2016 Jul 5;87(1):57-64. doi: 10.1212/WNL.0000000000002795. Epub 2016 Jun 15.

9.

Targeting protein homeostasis in sporadic inclusion body myositis.

Ahmed M, Machado PM, Miller A, Spicer C, Herbelin L, He J, Noel J, Wang Y, McVey AL, Pasnoor M, Gallagher P, Statland J, Lu CH, Kalmar B, Brady S, Sethi H, Samandouras G, Parton M, Holton JL, Weston A, Collinson L, Taylor JP, Schiavo G, Hanna MG, Barohn RJ, Dimachkie MM, Greensmith L.

Sci Transl Med. 2016 Mar 23;8(331):331ra41. doi: 10.1126/scitranslmed.aad4583.

10.

A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement.

Macchi Z, Wang Y, Moore D, Katz J, Saperstein D, Walk D, Simpson E, Genge A, Bertorini T, Fernandes JA, Swenson A, Elman L, Dimachkie M, Herbelin L, Miller J, Lu J, Wilkins H, Swerdlow RH, Statland J, Barohn R; Western ALS (WALS) Rasagiline Study Group.

Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5-6):345-52. doi: 10.3109/21678421.2015.1026826. Epub 2015 Apr 2.

11.

Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot.

Gajewski BJ, Berry SM, Quintana M, Pasnoor M, Dimachkie M, Herbelin L, Barohn R.

Stat Med. 2015 Mar 30;34(7):1134-49. doi: 10.1002/sim.6403. Epub 2015 Jan 7.

12.

Safety of aerobic exercise in people with diabetic peripheral neuropathy: single-group clinical trial.

Kluding PM, Pasnoor M, Singh R, D'Silva LJ, Yoo M, Billinger SA, LeMaster JW, Dimachkie MM, Herbelin L, Wright DE.

Phys Ther. 2015 Feb;95(2):223-34. doi: 10.2522/ptj.20140108. Epub 2014 Oct 2.

13.

Pompe disease: literature review and case series.

Dasouki M, Jawdat O, Almadhoun O, Pasnoor M, McVey AL, Abuzinadah A, Herbelin L, Barohn RJ, Dimachkie MM.

Neurol Clin. 2014 Aug;32(3):751-76, ix. doi: 10.1016/j.ncl.2014.04.010. Review.

14.

Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.

Trivedi JR, Bundy B, Statland J, Salajegheh M, Rayan DR, Venance SL, Wang Y, Fialho D, Matthews E, Cleland J, Gorham N, Herbelin L, Cannon S, Amato A, Griggs RC, Hanna MG, Barohn RJ; CINCH Consortium.

Brain. 2013 Jul;136(Pt 7):2189-200. doi: 10.1093/brain/awt133. Epub 2013 Jun 13.

15.

North America and South America (NA-SA) neuropathy project.

Pasnoor M, Nascimento OJ, Trivedi J, Wolfe GI, Nations S, Herbelin L, de Freitas MG, Quintanilha G, Khan S, Dimachkie M, Barohn R.

Int J Neurosci. 2013 Aug;123(8):563-7. doi: 10.3109/00207454.2013.782026. Epub 2013 Apr 17.

PMID:
23461611
16.

A pilot study to measure upper extremity H-reflexes following neuromuscular electrical stimulation therapy after stroke.

Stowe AM, Hughes-Zahner L, Barnes VK, Herbelin LL, Schindler-Ivens SM, Quaney BM.

Neurosci Lett. 2013 Feb 22;535:1-6. doi: 10.1016/j.neulet.2012.11.063. Epub 2013 Jan 8.

17.

Phase II trial of methotrexate in myasthenia gravis.

Pasnoor M, He J, Herbelin L, Dimachkie M, Barohn RJ; Muscle Study Group.

Ann N Y Acad Sci. 2012 Dec;1275:23-8. doi: 10.1111/j.1749-6632.2012.06804.x.

18.

Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial.

Statland JM, Bundy BN, Wang Y, Rayan DR, Trivedi JR, Sansone VA, Salajegheh MK, Venance SL, Ciafaloni E, Matthews E, Meola G, Herbelin L, Griggs RC, Barohn RJ, Hanna MG; Consortium for Clinical Investigation of Neurologic Channelopathies.

JAMA. 2012 Oct 3;308(13):1357-65. doi: 10.1001/jama.2012.12607.

19.

A quantitative measure of handgrip myotonia in non-dystrophic myotonia.

Statland JM, Bundy BN, Wang Y, Trivedi JR, Raja Rayan D, Herbelin L, Donlan M, McLin R, Eichinger KJ, Findlater K, Dewar L, Pandya S, Martens WB, Venance SL, Matthews E, Amato AA, Hanna MG, Griggs RC, Barohn RJ; CINCH Consortium.

Muscle Nerve. 2012 Oct;46(4):482-9. doi: 10.1002/mus.23402.

20.

Facial onset sensorimotor neuronopathy syndrome: a case series.

Dobrev D, Barhon RJ, Anderson NE, Kilfoyle D, Khan S, McVey AL, Herbelin L, Dimachkie MM.

J Clin Neuromuscul Dis. 2012 Sep;14(1):7-10. doi: 10.1097/CND.0b013e31825f82b3.

PMID:
22922575
22.

Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.

Mittal MK, Barohn RJ, Pasnoor M, McVey A, Herbelin L, Whittaker T, Dimachkie M.

J Clin Neuromuscul Dis. 2011 Sep;13(1):46-52. doi: 10.1097/CND.0b013e31821c5634.

PMID:
22361625
23.

An interactive voice response diary for patients with non-dystrophic myotonia.

Statland JM, Wang Y, Richesson R, Bundy B, Herbelin L, Gomes J, Trivedi J, Venance S, Amato A, Hanna M, Griggs R, Barohn RJ; Cinch Consortium.

Muscle Nerve. 2011 Jul;44(1):30-5. doi: 10.1002/mus.22007.

24.

Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy.

Mittal M, Pasnoor M, Mummaneni RB, Khan S, McVey A, Saperstein D, Herbelin L, Ridings L, Wang Y, Dimachkie MM, Barohn RJ.

Int J Neurosci. 2011 Sep;121(9):521-7. doi: 10.3109/00207454.2011.582238. Epub 2011 Jun 15.

25.

Autonomic nerve function in adult patients with cyclic vomiting syndrome.

Hejazi RA, Lavenbarg TH, Pasnoor M, Dimachkie M, Foran P, Herbelin L, McCallum RW.

Neurogastroenterol Motil. 2011 May;23(5):439-43. doi: 10.1111/j.1365-2982.2011.01679.x. Epub 2011 Feb 16.

PMID:
21323793
26.

Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.

Pasnoor M, Wolfe GI, Nations S, Trivedi J, Barohn RJ, Herbelin L, McVey A, Dimachkie M, Kissel J, Walsh R, Amato A, Mozaffar T, Hungs M, Chui L, Goldstein J, Novella S, Burns T, Phillips L, Claussen G, Young A, Bertorini T, Oh S.

Muscle Nerve. 2010 Mar;41(3):370-4. doi: 10.1002/mus.21533.

PMID:
19882635
27.

Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients.

Jackson CE, Gronseth G, Rosenfeld J, Barohn RJ, Dubinsky R, Simpson CB, McVey A, Kittrell PP, King R, Herbelin L; Muscle Study Group.

Muscle Nerve. 2009 Feb;39(2):137-43. doi: 10.1002/mus.21213.

PMID:
19145653
28.

Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity.

Jackson CE, Barohn RJ, Gronseth G, Pandya S, Herbelin L; Muscle Study Group.

Muscle Nerve. 2008 Apr;37(4):473-6. doi: 10.1002/mus.20958.

PMID:
18236463
29.

Pilot trial of etanercept in the treatment of inclusion-body myositis.

Barohn RJ, Herbelin L, Kissel JT, King W, McVey AL, Saperstein DS, Mendell JR.

Neurology. 2006 Jan 24;66(2 Suppl 1):S123-4.

PMID:
16432140
30.

Primary lateral sclerosis: clinical and laboratory features in 25 patients.

Singer MA, Kojan S, Barohn RJ, Herbelin L, Nations SP, Trivedi JR, Jackson CE, Burns DK, Boyer PJ, Wolfe GI.

J Clin Neuromuscul Dis. 2005 Sep;7(1):1-9. doi: 10.1097/01.cnd.0000176974.61136.45.

PMID:
19078775
31.

Myopathy with skeletal asymmetry and hemidiaphragm elevation is caused by myotubularin mutations.

Grogan PM, Tanner SM, Ørstavik KH, Knudsen GP, Saperstein DS, Vogel H, Barohn RJ, Herbelin LL, McVey AL, Katz JS.

Neurology. 2005 May 10;64(9):1638-40.

PMID:
15883335
32.

Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjögren's syndrome.

Wolfe GI, Nations SP, Burns DK, Herbelin LL, Barohn RJ.

Neurology. 2003 Sep 23;61(6):873; author reply 873. No abstract available.

PMID:
14723230
33.

Challenges in the identification of cobalamin-deficiency polyneuropathy.

Saperstein DS, Wolfe GI, Gronseth GS, Nations SP, Herbelin LL, Bryan WW, Barohn RJ.

Arch Neurol. 2003 Sep;60(9):1296-301.

PMID:
12975298
34.

Myasthenia gravis activities of daily living profile.

Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ.

Neurology. 1999 Apr 22;52(7):1487-9.

PMID:
10227640
35.

Magnetic resonance imaging of muscle in amyotrophic lateral sclerosis.

Bryan WW, Reisch JS, McDonald G, Herbelin LL, Barohn RJ, Fleckenstein JL.

Neurology. 1998 Jul;51(1):110-3.

PMID:
9674787
36.

Reliability testing of the quantitative myasthenia gravis score.

Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan WW.

Ann N Y Acad Sci. 1998 May 13;841:769-72. No abstract available.

PMID:
9668327

Supplemental Content

Loading ...
Support Center